Federal contract award

75N92B21P00064

TAKARA BIO USA, INC.:1109645 [21-004466] - NIAMS REQUEST THE PURCHASE OF A KIT AND CONSUMABLES FOR OUR ICELL8 CX SINGLE-CELL SYSTEM FROM TAKARA BIO USA, THIS IS A SYSTEM THAT PROVIDE A HIGH-THROUGHPUT METHOD TO ISOLATE SINGLE CELLS OF ANY SIZE AND NU

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNIH NIAMS
NAICS325414 — Biological Product (except Diagnostic) Manufacturing
PSC6810 — Chemicals
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIRM FIXED PRICE
Obligations$11.0K
Current contract value$11.0K
Potential contract value / ceiling$11.0K
Start dateAug 26, 2021
Current end dateSep 2, 2021
Potential end dateSep 2, 2021
Latest award activityJul 20, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jul 20, 2026P00001$-100TAKARA BIO USA, INC.:1109645 [21-004466] - NIAMS REQUEST THE PURCHASE OF A KIT AND CONSUMABLES FOR OUR ICELL8 CX SINGLE-CELL SYSTEM FROM TAKARA BIO USA, THIS IS A SYSTEM THAT PROVIDE A HIGH-THROUGHPUT METHOD TO ISOLATE SINGLE CELLS OF ANY SIZE AND NU
Aug 26, 20210$11.1KTAKARA BIO USA, INC.:1109645 [21-004466] - NIAMS REQUEST THE PURCHASE OF A KIT AND CONSUMABLES FOR OUR ICELL8 CX SINGLE-CELL SYSTEM FROM TAKARA BIO USA, THIS IS A SYSTEM THAT PROVIDE A HIGH-THROUGHPUT METHOD TO ISOLATE SINGLE CELLS OF ANY SIZE AND NU

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.